Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery.


Journal

Neoplasia (New York, N.Y.)
ISSN: 1476-5586
Titre abrégé: Neoplasia
Pays: United States
ID NLM: 100886622

Informations de publication

Date de publication:
07 2021
Historique:
received: 17 03 2021
revised: 28 04 2021
accepted: 30 04 2021
pubmed: 18 6 2021
medline: 18 1 2022
entrez: 17 6 2021
Statut: ppublish

Résumé

The blood-brain barrier (BBB) is a major anatomical and physiological barrier limiting the passage of drugs into brain. Central nervous system tumors can impair the BBB by changing the tumor microenvironment leading to the formation of a leaky barrier, known as the blood-tumor barrier (BTB). Despite the change in integrity, the BTB remains effective in preventing delivery of chemotherapy into brain tumors. Focused ultrasound is a unique noninvasive technique that can transiently disrupt the BBB and increase accumulation of drugs within targeted areas of the brain. Herein, we summarize the current understanding of different types of targeted ultrasound mediated BBB/BTB disruption techniques. We also discuss influence of the tumor microenvironment on BBB opening, as well as the role of immunological response following disruption. Lastly, we highlight the gaps between evaluation of the parameters governing opening of the BBB/BTB. A deeper understanding of physical opening of the BBB/BTB and the biological effects following disruption can potentially enhance treatment strategies for patients with brain tumors.

Identifiants

pubmed: 34139452
pii: S1476-5586(21)00025-7
doi: 10.1016/j.neo.2021.04.005
pmc: PMC8208897
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

676-691

Subventions

Organisme : NCI NIH HHS
ID : F99 CA253768
Pays : United States
Organisme : NCI NIH HHS
ID : F99 CA264445
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM121322
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Sci Transl Med. 2016 Jun 15;8(343):343re2
pubmed: 27306666
PLoS One. 2008;3(10):e3511
pubmed: 18958151
J Mol Neurosci. 2012 Mar;46(3):677-87
pubmed: 21861133
Cold Spring Harb Perspect Biol. 2015 Jan 05;7(1):a020412
pubmed: 25561720
Clin Cancer Res. 2019 Jul 1;25(13):3793-3801
pubmed: 30890548
Pharmacol Res. 2017 Sep;123:10-25
pubmed: 28634084
Sci Rep. 2016 Sep 15;6:33264
pubmed: 27630037
Front Oncol. 2018 Aug 28;8:338
pubmed: 30211117
Neurobiol Dis. 2010 Jan;37(1):13-25
pubmed: 19664713
Biomed Eng Lett. 2017 Jan 9;7(2):135-142
pubmed: 30603160
Trends Immunol. 2015 Oct;36(10):569-577
pubmed: 26431936
J Ther Ultrasound. 2014 Oct 16;2:17
pubmed: 25671132
J Neurosurg. 2020 Jan 3;:1-9
pubmed: 31899873
Circ Cardiovasc Imaging. 2017 Apr;10(4):
pubmed: 28377467
Neurosurg Focus. 2018 Feb;44(2):E16
pubmed: 29385923
AJNR Am J Neuroradiol. 2019 Mar;40(3):470-477
pubmed: 30792254
J Transl Med. 2015;13:93
pubmed: 25784614
J Cereb Blood Flow Metab. 2007 Feb;27(2):393-403
pubmed: 16685254
ScientificWorldJournal. 2011;11:1829-41
pubmed: 22125441
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9180-9182
pubmed: 32284421
Annu Rev Med. 2009;60:417-30
pubmed: 19630579
Circ Res. 2009 Mar 13;104(5):679-87
pubmed: 19168443
Nat Commun. 2019 Sep 26;10(1):4373
pubmed: 31558719
Neurosurg Focus. 2018 Feb;44(2):E11
pubmed: 29385926
Neurosurg Focus. 2018 Feb;44(2):E15
pubmed: 29385915
Neurotherapeutics. 2019 Jan;16(1):67-87
pubmed: 30406382
Front Cell Neurosci. 2014 Dec 12;8:418
pubmed: 25565956
J Therm Biol. 2019 Jul;83:119-133
pubmed: 31331510
Fluids Barriers CNS. 2019 Jan 29;16(1):3
pubmed: 30691500
Nihon Yakurigaku Zasshi. 2018;151(1):4-8
pubmed: 29321395
Theranostics. 2018 Feb 5;8(6):1481-1493
pubmed: 29556336
Cancer Res. 2017 Jan 15;77(2):238-246
pubmed: 27815391
Ultrasound Med Biol. 2006 Sep;32(9):1399-409
pubmed: 16965980
Neurosurgery. 2010 Feb;66(2):323-32; discussion 332
pubmed: 20087132
Acta Neuropathol. 2003 Jun;105(6):586-92
pubmed: 12734665
J Neurosurg. 2016 Jun;124(6):1602-10
pubmed: 26566207
Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8717-E8726
pubmed: 30150398
Phys Med Biol. 2018 Mar 15;63(6):065009
pubmed: 29457587
Nat Rev Cancer. 2020 Jan;20(1):26-41
pubmed: 31601988
Curr Pharm Des. 2016;22(9):1177-1193
pubmed: 26685681
Clin Cancer Res. 2010 Dec 1;16(23):5664-78
pubmed: 20829328
J Cereb Blood Flow Metab. 2011 Feb;31(2):725-37
pubmed: 20842160
Proc Natl Acad Sci U S A. 2017 Jan 3;114(1):E75-E84
pubmed: 27994152
FEBS J. 2015 Nov;282(21):4067-79
pubmed: 26277326
J Neurosurg. 2013 Oct;119(4):887-98
pubmed: 23790118
J Neurooncol. 2021 Jan;151(1):65-73
pubmed: 32112296
J Transl Med. 2007 Jul 11;5:34
pubmed: 17625013
Sci Adv. 2021 Feb 5;7(6):
pubmed: 33547073
Ther Clin Risk Manag. 2019 Feb 04;15:233-240
pubmed: 30787618
J Neuroinflammation. 2019 Jul 25;16(1):155
pubmed: 31345243
J Neurosurg. 2017 Apr;126(4):1351-1361
pubmed: 27285538
J Transl Med. 2020 Jan 3;18(1):1
pubmed: 31900168
Theranostics. 2021 Jan 1;11(4):1655-1671
pubmed: 33408773
Adv Healthc Mater. 2017 Nov;6(21):
pubmed: 28766896
J Pharm Biomed Anal. 2018 Feb 5;149:482-487
pubmed: 29175555
Theranostics. 2017 Sep 15;7(16):3989-4000
pubmed: 29109793
Int J Nanomedicine. 2017 Aug 09;12:5613-5629
pubmed: 28848341
Cell Tissue Res. 2019 Jan;375(1):287-293
pubmed: 30535799
Radiology. 2021 Mar;298(3):654-662
pubmed: 33399511
Acta Neuropathol. 2018 Mar;135(3):311-336
pubmed: 29411111
Neuro Oncol. 2015 Feb;17(2):289-95
pubmed: 25015089
Front Neurosci. 2019 Jul 24;13:696
pubmed: 31396029
Trends Cancer. 2019 Aug;5(8):495-505
pubmed: 31421906
JAMA Neurol. 2018 Feb 1;75(2):246-254
pubmed: 29228074
ACS Chem Neurosci. 2010 May 19;1(5):391-398
pubmed: 20563295
J Pediatr Hematol Oncol. 2019 Oct;41(7):e443-e449
pubmed: 31449496
Prog Biophys Mol Biol. 2007 Jan-Apr;93(1-3):374-83
pubmed: 16970981
J Am Soc Echocardiogr. 2003 Nov;16(11):1178-85
pubmed: 14608290
Ultrasound Med Biol. 2007 Apr;33(4):584-90
pubmed: 17337109
Drug Discov Today Technol. 2016 Jun;20:41-48
pubmed: 27986222
Neuro Oncol. 2018 Jan 22;20(2):184-191
pubmed: 29016900
J Neurooncol. 2019 Aug;144(1):33-41
pubmed: 31197598
J Ther Ultrasound. 2016 Jan 22;4:2
pubmed: 26807257
J Control Release. 2020 Aug 10;324:450-459
pubmed: 32470359
J Ultrasound Med. 2017 May;36(5):941-953
pubmed: 28240842
Ultrasound Med Biol. 2008 Jun;34(6):930-7
pubmed: 18294757
Sci Rep. 2019 Jan 23;9(1):321
pubmed: 30674905
Theranostics. 2017 Aug 23;7(15):3608-3623
pubmed: 29109764
Expert Rev Neurother. 2019 Oct;19(10):937-943
pubmed: 31232614
Sci Rep. 2018 May 29;8(1):8267
pubmed: 29844613

Auteurs

T A Arsiwala (TA)

Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, HSC, Morgantown, WV.

S A Sprowls (SA)

Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, HSC, Morgantown, WV.

K E Blethen (KE)

Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, HSC, Morgantown, WV.

C E Adkins (CE)

School of Pharmacy, South University, Savannah, GA.

P A Saralkar (PA)

Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, HSC, Morgantown, WV.

R A Fladeland (RA)

Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, HSC, Morgantown, WV.

W Pentz (W)

Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, HSC, Morgantown, WV.

A Gabriele (A)

Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, HSC, Morgantown, WV.

B Kielkowski (B)

Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, HSC, Morgantown, WV.

R I Mehta (RI)

Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV; Department of Neuroradiology, West Virginia University, Morgantown, WV; Department of Neuroscience, West Virginia University, Morgantown, WV.

P Wang (P)

Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV; Department of Neuroradiology, West Virginia University, Morgantown, WV.

J S Carpenter (JS)

Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV; Department of Neuroradiology, West Virginia University, Morgantown, WV.

M Ranjan (M)

Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV; Departments of Neuroscience and Neurosurgery, West Virginia University, Morgantown, WV.

U Najib (U)

Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV; Department of Neurology, West Virginia University, Morgantown, WV.

A R Rezai (AR)

Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV; Departments of Neuroscience and Neurosurgery, West Virginia University, Morgantown, WV.

P R Lockman (PR)

Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, HSC, Morgantown, WV. Electronic address: prlockman@wvu.hsc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH